JPWO2022234856A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022234856A5
JPWO2022234856A5 JP2023518703A JP2023518703A JPWO2022234856A5 JP WO2022234856 A5 JPWO2022234856 A5 JP WO2022234856A5 JP 2023518703 A JP2023518703 A JP 2023518703A JP 2023518703 A JP2023518703 A JP 2023518703A JP WO2022234856 A5 JPWO2022234856 A5 JP WO2022234856A5
Authority
JP
Japan
Prior art keywords
cells
memory
naive
differentiation
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023518703A
Other languages
English (en)
Japanese (ja)
Other versions
JP7692633B2 (ja
JPWO2022234856A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/019563 external-priority patent/WO2022234856A1/ja
Publication of JPWO2022234856A1 publication Critical patent/JPWO2022234856A1/ja
Publication of JPWO2022234856A5 publication Critical patent/JPWO2022234856A5/ja
Application granted granted Critical
Publication of JP7692633B2 publication Critical patent/JP7692633B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023518703A 2021-05-07 2022-05-06 メモリーｔ細胞の製造方法 Active JP7692633B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021079296 2021-05-07
JP2021079296 2021-05-07
PCT/JP2022/019563 WO2022234856A1 (ja) 2021-05-07 2022-05-06 メモリーｔ細胞の製造方法

Publications (3)

Publication Number Publication Date
JPWO2022234856A1 JPWO2022234856A1 (https=) 2022-11-10
JPWO2022234856A5 true JPWO2022234856A5 (https=) 2024-02-09
JP7692633B2 JP7692633B2 (ja) 2025-06-16

Family

ID=83932780

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023518703A Active JP7692633B2 (ja) 2021-05-07 2022-05-06 メモリーｔ細胞の製造方法

Country Status (4)

Country Link
US (1) US20240368545A1 (https=)
EP (1) EP4321613A4 (https=)
JP (1) JP7692633B2 (https=)
WO (1) WO2022234856A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014153363A1 (en) 2013-03-18 2014-09-25 Northeastern University Method for generation of broadly neutralizing anti-pathogen antibodies
BR112020005552A2 (pt) 2017-09-20 2020-10-27 Neximmune, Inc. composições de células compreendendo células t específicas de antígeno para terapia adotiva
JP7698577B2 (ja) 2018-10-18 2025-06-25 ボード オブ リージェンツ ザ ユニヴァーシティ オブ テキサス システム 組織常在メモリー様ｔ細胞を生成するための方法及びその使用
SG11202104611YA (en) 2018-11-08 2021-06-29 Neximmune Inc T cell compositions with improved phenotypic properties
JP2021079296A (ja) 2021-03-08 2021-05-27 株式会社三洋物産 遊技機

Similar Documents

Publication Publication Date Title
Woods et al. Autologous germline mitochondrial energy transfer (AUGMENT) in human assisted reproduction
JP2020518289A5 (https=)
James et al. 7 Blastocladiomycota
HRP20250068T1 (hr) Postupci proizvodnje tumor-infiltrirajućih limfocita i uporabe istih u imunoterapiji
CN102517253A (zh) 一种脐带血调节性t细胞体外扩增及低温保存方法
Zych et al. Micropropagation of Rhodiola kirilowii plants using encapsulated axillary buds and callus
WO2020151097A1 (zh) 人参形成层干细胞分离培养方法
JP2012143229A5 (https=)
CN105543169A (zh) 一种人tscm细胞的制备方法及应用
CN108060119B (zh) 小分子化合物组合及利用该小分子化合物组合诱导分化的细胞制备血管平滑肌细胞的方法
US8506952B2 (en) Probiotic compositions and process thereof
CN105143441A (zh) 用带有活性因子的细胞空壳作为淋巴细胞体外培养增效剂的制备及其应用方法
JP2013507945A5 (https=)
JPWO2022234856A5 (https=)
EP3406704B1 (en) Modification method for adhesion-state cell culture
CN105176926A (zh) 一种体外培养扩增nk细胞的方法
WO2021015615A8 (en) Low density cell culture
Mohanta et al. In vitro culture of highly valuable medicinal plant Bacopa monnieri (L.) Penn. for rapid and mass multiplication
CN103755417B (zh) 一种富硒猴头菌菌丝体液体发酵的生产方法
JP2011527192A5 (https=)
JP2022541788A5 (https=)
CN110157663B (zh) 一种干细胞体外诱导培育心肌细胞的方法
RU2410425C1 (ru) Питательная среда для культивирования микобактерий туберкулеза
FR3008317A1 (fr) Utilisation de microorganismes pour diminuer le taux de trimethylamine dans une cavite du corps humain, notamment pour le traitement de la trimethylaminurie ou d'une vaginose bacterienne et la prevention des maladies cardiovasculaires
Kokorev et al. Co-Transplantation of pancreatic islet cells and mesenchymal bone marrow precursors on titanium nickelide scaffolds in alloxan-induced diabetes mellitus